INTIMATION FOR APPOINTMENT OF INTERNAL AUDITOR AND SECRETARIAL AUDITOR OF THE COMPANY
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Samsrita Labs Ltd (formerly Dr Habeebullah Life Sciences Ltd) announced outcomes of its board meeting held on April 26, 2025. The board approved the appointment of M/s Tungala & Co. as Internal Auditor for FY 2025-26 and Manoj Parakh & Associates as Secretarial Auditor for 5 years (subject to shareholder approval). The company also declared its audited financial results for Q4 and FY ended March 31, 2025. The company reported zero revenue from operations and a net loss of ₹25.95 lakhs for FY25, slightly wider than the ₹24.99 lakh loss in FY24. EPS stood at (0.18) and reserves & surplus remained negative at (₹272.50 lakhs).
This is largely a routine governance update with no major operational news, but the widening losses and zero revenue highlight ongoing business challenges. No direct material impact on share price is expected from the auditor appointments alone.